These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25446151)

  • 21. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
    Wang Y; Cui YH; Wang DW
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
    Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
    Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slowed atrial and atrioventricular conduction and depressed HRV in a murine model of hypertrophic cardiomyopathy.
    Lim WW; Baumert M; Neo M; Kuklik P; Ganesan AN; Lau DH; Tsoutsman T; Semsarian C; Sanders P; Saint DA
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):95-101. PubMed ID: 26444142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients.
    Bent RE; Wheeler MT; Hadley D; Froelicher V; Ashley E; Perez MV
    J Electrocardiol; 2015; 48(3):362-7. PubMed ID: 25732098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A founder MYBPC3 mutation results in HCM with a high risk of sudden death after the fourth decade of life.
    Calore C; De Bortoli M; Romualdi C; Lorenzon A; Angelini A; Basso C; Thiene G; Iliceto S; Rampazzo A; Melacini P
    J Med Genet; 2015 May; 52(5):338-47. PubMed ID: 25740977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertrophic cardiomyopathy: electrocardiographic manifestations and other important considerations for the emergency physician.
    Kelly BS; Mattu A; Brady WJ
    Am J Emerg Med; 2007 Jan; 25(1):72-9. PubMed ID: 17157688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.
    Maron BJ; Semsarian C; Shen WK; Link MS; Epstein AE; Estes NA; Almquist A; Giudici MC; Haas TS; Hodges JS; Spirito P
    Heart Rhythm; 2009 May; 6(5):599-602. PubMed ID: 19332391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
    J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypertrophic cardiomyopathy -- modern state of the problem. Issues of epidemiology and nomenclature, genetics and pathophysiology, variants of course and differential diagnosis].
    Belenkov IuN; Privalova EV; Kaplunova VIu; Khabarova NV; Shakar'iants GA
    Kardiologiia; 2013; 53(5):4-12. PubMed ID: 23952988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: results from Kochi RYOMA study.
    Kubo T; Kitaoka H; Okawa M; Hirota T; Hayato K; Yamasaki N; Matsumura Y; Yabe T; Doi YL
    J Cardiol; 2010 Nov; 56(3):314-9. PubMed ID: 20719473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sudden cardiac arrest in a young patient with hypertrophic cardiomyopathy and zero canonical risk factors: the inherent limitations of risk stratification in hypertrophic cardiomyopathy.
    Kohorst JJ; Bos JM; Hagler DJ; Ackerman MJ
    Congenit Heart Dis; 2014; 9(2):E51-7. PubMed ID: 23648018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sports and Exercise in Athletes with Hypertrophic Cardiomyopathy.
    Alpert C; Day SM; Saberi S
    Clin Sports Med; 2015 Jul; 34(3):489-505. PubMed ID: 26100424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of clinical features of pregnant women with hypertrophic cardiomyopathy].
    Hu YH; Huang TT; Zhuang X; Lin JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):486-9. PubMed ID: 24284216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis.
    Briasoulis A; Mallikethi-Reddy S; Palla M; Alesh I; Afonso L
    Heart; 2015 Sep; 101(17):1406-11. PubMed ID: 26060120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation: advanced echocardiographic evaluation of the left atrium combined with non-invasive P-wave analysis.
    Girasis C; Vassilikos V; Efthimiadis GK; Papadopoulou SL; Dakos G; Dalamaga EG; Chouvarda I; Giannakoulas G; Kamperidis V; Paraskevaidis S; Maglaveras N; Karvounis HI; Parcharidis GE; Styliadis IH
    Eur Heart J Cardiovasc Imaging; 2013 May; 14(5):425-34. PubMed ID: 22902322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of left atrial appendage function during sinus rhythm in patients with hypertrophic cardiomyopathy: transesophageal echocardiography and tissue doppler study.
    Yakar Tuluce S; Kayikcioglu M; Tuluce K; Yilmaz MG; Ozdogan O; Aydın M; Hasdemir C
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1207-16. PubMed ID: 20869845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy.
    Cambronero F; Vilchez JA; García-Honrubia A; Ruiz-Espejo F; Moreno V; Hernández-Romero D; Bonacasa B; González-Conejero R; de la Morena G; Martínez P; Climent V; Valdés M; Marín F
    Thromb Res; 2010 Jul; 126(1):e46-50. PubMed ID: 20156645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
    Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.